Ladenburg Thalmann Financial Services’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-26	Closed	–	–	5237
2017 Q4	$0	Hold	26	–	–	﹤0.01%	5149
2017 Q3	$0	Sell	26 -1,475	-98%	-$1.83K	﹤0.01%	5054
2017 Q2	$2K	Buy	1,501 +26	+2%	+$50	﹤0.01%	4637
2017 Q1	$5K	Buy	1,475 +93	+7%	+$229	﹤0.01%	4336
2016 Q4	$2K	Sell	1,382 -158	-10%	-$206	﹤0.01%	4570
2016 Q3	$2K	Hold	1,540	–	–	﹤0.01%	4530
2016 Q2	$2K	Sell	1,540 -108	-7%	-$505	﹤0.01%	4451
2016 Q1	$9K	Sell	1,648 -132	-7%	-$808	﹤0.01%	3780
2015 Q4	$14K	Hold	1,780	–	–	﹤0.01%	3485
2015 Q3	$15K	Buy	1,780 +1,741	+4,464%	+$16.1K	﹤0.01%	3295
2015 Q2	$0	Hold	39	–	–	﹤0.01%	4782
2015 Q1	$1K	Hold	39	–	–	﹤0.01%	4476
2014 Q4	$1K	Hold	39	–	–	﹤0.01%	4261
2014 Q3	$1K	Hold	39	–	–	﹤0.01%	3838
2014 Q2	$0	Buy	+39	New	+$406	﹤0.01%	4000
2014 Q1	–	Sell	-1,500	Closed	-$21K	–	3879
2013 Q4	$21K	Buy	+1,500	New	+$21.2K	﹤0.01%	2514
2013 Q3	–	Sell	-1,000	Closed	-$16K	–	3853
2013 Q2	$16K	Buy	+1,000	New	+$30.9K	﹤0.01%	2468

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GTC

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ladenburg Thalmann Financial Services's INFI Position: Q1 2018 in Review

Ladenburg Thalmann Financial Services sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2018, closing a stake of 26 shares.

Ladenburg Thalmann Financial Services first reported a position in INFI in Q2 2013 and held it in 17 quarters. The position peaked at $21K in Q4 2013. 66 funds tracked by Wall St. Rank hold INFI as of Q1 2018.

Ladenburg Thalmann Financial Services reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 26 Infinity Pharmaceuticals, Inc. shares in Q1 2018.
Ladenburg Thalmann Financial Services first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 17 quarters.
Ladenburg Thalmann Financial Services's Infinity Pharmaceuticals, Inc. position peaked at $21K in Q4 2013.
66 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2018, filed 15 May 2018.